BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8988694)

  • 21. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal anti-D development programme.
    Kumpel BM
    Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
    Crowther CA; Keirse MJ
    Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 31. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L; Napier JA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of maternal alloimmunisation to Rh D in Northern Ireland.
    McCauley CJ; Morris K; Maguire K
    Transfus Med; 2017 Apr; 27(2):132-135. PubMed ID: 28101958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Kleihauer test in Rhesus negative pregnancy.
    Mahboob U; Mazhar SB
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):120-3. PubMed ID: 16499805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in deaths from rhesus haemolytic disease of the newborn.
    Clarke C; Hussey RM
    J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of immunoprophylaxis with anti-D immunoglobin.
    Engelfriet CP; Reesink HW; Judd WJ; Ulander VM; Kuosmanen M; Koskinen S; Rouger P; Morelati F; Tantalo V; Fujii T; de Haas M; van der Schoot CE; Overbeeke M; Koelewijn J; Bonsel G; Vrijkotte T; Zupańska B; Martin-Vega C; Parra Lopez R; de Silva M; Contreras M; Panzer S; Ulm B; Mayr WR
    Vox Sang; 2003 Nov; 85(4):328-37. PubMed ID: 14633261
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is antenatal antibody screening worthwhile in the Zimbabwean population?
    Cakana AZ; Ngwenya L
    Cent Afr J Med; 2000 Feb; 46(2):38-41. PubMed ID: 14674207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.